4-Hydroxy-triazolam
CAS: 65686-11-5
Ref. 3D-QCA68611
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Informação sobre produto
- 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepin-4-ol, 8-chloro-6-(2-chlorophenyl)-1-methyl-
4-Hydroxy-triazolam is an analog of triazolam that has shown promising anticancer activity. It has been found to induce apoptosis in cancer cells and inhibit the growth of tumors. This compound is excreted primarily in urine and has been studied extensively as a potential inhibitor of kinases and elastase, both of which are involved in cancer progression. 4-Hydroxy-triazolam has also been investigated for its potential use as an anticancer drug in Chinese medicine. Although it shares some structural similarities with etomidate, a general anesthetic, it has distinct pharmacological properties that make it a promising candidate for further study as a cancer therapy.
Propriedades químicas
Consulta técnica sobre: 3D-QCA68611 4-Hydroxy-triazolam
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.